Prospects of using the genetically engineered preparation dupilumab for the treatment of atopic dermatitis in the adult population. Journal of Pakistan Association of Dermatologists, [S. l.], v. 32, n. 2, p. 327–333, 2022. DOI: 10.66344/jpad.v32i2.1900. Disponível em: https://www.jpad.com.pk/index.php/jpad/article/view/1900. Acesso em: 24 aug. 2026.